GH1 and cancer: The effect of C#1 is attributed to a reduction in both the endo- and endocrine activities of the GH/IGF1 axis with the potential to inhibit GH-driven cancer growth [11], although the same compound appeared to have DHFR inhibitory effects in vitro as well [14] and acts as an antifolate.